Lexington, KYNCT06967389Now EnrollingIRB Ready

Obesity and Overweight Clinical Trial in Lexington, KY

Access cutting-edge obesity and overweight treatment through this clinical trial at a research site in Lexington. Study-provided care at no cost to qualified participants.

Sponsored by John Bauer

Quick Self-Assessment

See if you qualify for this Lexington location

Preparing your pre-screening questions…

Expert Care in Lexington

Access obesity and overweight specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related obesity and overweight treatment provided free

Apply for This Lexington Location

Check if you qualify for this obesity and overweight clinical trial in Lexington, KY

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Lexington

    Convenient for KY residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Lexington site if eligible
  4. 4Begin participation

About This Obesity and Overweight Study in Lexington

The goal of this clinical trial is to learn if the drug semaglutide changes markers of disease risk as it relates to weight in children ages 12-15 years old who are obese (class 2 or 3). The main questions it aims to answer are: * How do the rate of weight loss, body mass index (BMI), body composition, heart structure and function, and exercise ability interact with one another in the study population at enrollment? * How do risk markers of disease change over the study in the study participants who are given semaglutides to help with weight loss? * Are there differences in the above factors between males and females and are there key factors to help improve the outcomes? Participants will be given semaglutide for this study. During the course of the study, participants will: * have two cardiac MRI scans OR two cardiac echocardiograms (one before starting semaglutide and one around 12 months after taking the drug) * have body composition and fitness levels assessed twice (before semaglutide and around 12 months after taking it) and have urine specific gravity (USG) measured * have extra blood drawn when labs their doctor orders are already being drawn (once at the beginning of the study, once around 6 months after enrollment, and once at the end of the study) * have follow up visits with the study doctor * be asked to take a pregnancy test if they are female and have started menstruation

Sponsor: John Bauer

Who Can Participate

Inclusion Criteria

Patient seen at University of Kentucky Pediatric High BMI Clinic
Diagnosis of Obesity Class 2 or 3
Meeting the clinical criteria for the medical intervention with semaglutide for weight loss

Exclusion Criteria

Any current prescribed anti-obesity medications (AOM) such as Orlistat, Phentermine, Qsymia (Phentermine/Topiramate), Liraglutide, Semaglutide, and Setmelanotide
Any current prescribed anti-hypertensive medications
Any specific end-organ acute concerns (kidney disease, liver disease, congenital disease).
Any active infections at enrollment.
Any systemic steroid use longer than 3 month use or within the last month before enrollment (not including inhaled, ophthalmic, intranasal, and topical).
Any limitations that would make exercise testing not possible.
Any congenital abnormality or genetic syndrome known to be associated with obesity
Inability to receive an MRI
Personal or family history of medullary thyroid carcinoma (per product insert)
Patients with Multiple Endocrine Neoplasia syndrome type 2 (per product insert)

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Lexington?

Yes, this clinical trial (NCT06967389) has an active research site in Lexington, KY that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Obesity and Overweight Treatment Options in Lexington, KY

If you're searching for obesity and overweight treatment options in Lexington, KY, this clinical trial (NCT06967389) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Lexington research site is actively enrolling participants for this clinical trial. You'll receive care from experienced obesity and overweight specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all obesity and overweight clinical trials near you to find additional studies recruiting in your area.

More Obesity Trials in Lexington, KY

See all obesity clinical trials recruiting in Lexington — not just this study.

Browse Obesity Trials in Lexington

Browse More Trials by Condition

Ready to Join in Lexington?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Lexington, KY